Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer

BACKGROUND: Breast cancer is the most common malignancy in women, and neoadjuvant chemotherapy has been recommended to the patients with locally advanced breast cancer as the initial treatments. Long non-coding RNA (lncRNA) MEG3, an identified tumor suppressor, has been implicated in the development...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Bayarmaa, Battseren, Wu, Ziping, Peng, Jing, Wang, Yan, Xu, Shuguang, Yan, Tingting, Yin, Wenjin, Lu, Jinsong, Zhou, Liheng
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6727505/
https://ncbi.nlm.nih.gov/pubmed/31488093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6077-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky